Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

LFWD vs GMED vs SYK vs MDT vs ISRG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
LFWD
Lifeward Ltd.

Medical - Devices

HealthcareNASDAQ • IL
Market Cap$10M
5Y Perf.-93.9%
GMED
Globus Medical, Inc.

Medical - Devices

HealthcareNYSE • US
Market Cap$11.51B
5Y Perf.+42.6%
SYK
Stryker Corporation

Medical - Devices

HealthcareNYSE • US
Market Cap$112.69B
5Y Perf.+45.8%
MDT
Medtronic plc

Medical - Devices

HealthcareNYSE • IE
Market Cap$99.94B
5Y Perf.-22.8%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$161.07B
5Y Perf.+132.8%

LFWD vs GMED vs SYK vs MDT vs ISRG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
LFWD logoLFWD
GMED logoGMED
SYK logoSYK
MDT logoMDT
ISRG logoISRG
IndustryMedical - DevicesMedical - DevicesMedical - DevicesMedical - DevicesMedical - Instruments & Supplies
Market Cap$10M$11.51B$112.69B$99.94B$161.07B
Revenue (TTM)$22M$3.10B$25.12B$35.48B$10.58B
Net Income (TTM)$-20M$587M$3.25B$4.61B$2.98B
Gross Margin38.3%50.9%63.5%61.9%66.3%
Operating Margin-76.7%17.2%22.4%17.9%30.5%
Forward P/E16.7x19.1x13.8x43.3x
Total Debt$2M$119M$14.86B$28.52B$303M
Cash & Equiv.$2M$526M$4.01B$2.22B$3.37B

LFWD vs GMED vs SYK vs MDT vs ISRGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

LFWD
GMED
SYK
MDT
ISRG
StockMay 20May 26Return
Lifeward Ltd. (LFWD)1006.1-93.9%
Globus Medical, Inc. (GMED)100142.6+42.6%
Stryker Corporation (SYK)100145.8+45.8%
Medtronic plc (MDT)10077.2-22.8%
Intuitive Surgical,… (ISRG)100232.8+132.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: LFWD vs GMED vs SYK vs MDT vs ISRG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MDT leads in 4 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and capital preservation and lower volatility. Intuitive Surgical, Inc. is the stronger pick specifically for growth and revenue expansion and profitability and margin quality. GMED also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
LFWD
Lifeward Ltd.
The Healthcare Pick

LFWD lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
GMED
Globus Medical, Inc.
The Growth Play

GMED ranks third and is worth considering specifically for growth exposure and valuation efficiency.

  • Rev growth 16.7%, EPS growth 422.7%, 3Y rev CAGR 42.2%
  • PEG 0.54 vs MDT's 35.17
  • +19.0% vs LFWD's -58.3%
Best for: growth exposure and valuation efficiency
SYK
Stryker Corporation
The Lower-Volatility Pick

Among these 5 stocks, SYK doesn't own a clear edge in any measured category.

Best for: healthcare exposure
MDT
Medtronic plc
The Income Pick

MDT carries the broadest edge in this set and is the clearest fit for income & stability and defensive.

  • Dividend streak 36 yrs, beta 0.47, yield 3.6%
  • Beta 0.47, yield 3.6%, current ratio 1.85x
  • Lower P/E (13.8x vs 43.3x)
  • Beta 0.47 vs GMED's 1.29
Best for: income & stability and defensive
ISRG
Intuitive Surgical, Inc.
The Long-Run Compounder

ISRG is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.

  • 5.5% 10Y total return vs GMED's 264.4%
  • Lower volatility, beta 1.02, Low D/E 1.7%, current ratio 4.87x
  • 20.5% revenue growth vs LFWD's -14.1%
  • 28.2% margin vs LFWD's -90.4%
Best for: long-term compounding and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthISRG logoISRG20.5% revenue growth vs LFWD's -14.1%
ValueMDT logoMDTLower P/E (13.8x vs 43.3x)
Quality / MarginsISRG logoISRG28.2% margin vs LFWD's -90.4%
Stability / SafetyMDT logoMDTBeta 0.47 vs GMED's 1.29
DividendsMDT logoMDT3.6% yield, 36-year raise streak, vs SYK's 1.1%, (3 stocks pay no dividend)
Momentum (1Y)GMED logoGMED+19.0% vs LFWD's -58.3%
Efficiency (ROA)MDT logoMDT175.8% ROA vs LFWD's -78.4%, ROIC 6.0% vs -122.9%

LFWD vs GMED vs SYK vs MDT vs ISRG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

LFWDLifeward Ltd.
FY 2025
Product
100.0%$17M
GMEDGlobus Medical, Inc.
FY 2024
Spine
93.9%$2.4B
Emerging Technology
6.1%$154M
SYKStryker Corporation
FY 2025
MedSurg
62.3%$15.6B
Orthopaedics
37.7%$9.5B
MDTMedtronic plc
FY 2025
Cardiac and Vascular Group
37.3%$12.5B
Neuroscience Group
29.4%$9.8B
Medical Surgical
25.1%$8.4B
Diabetes Group
8.2%$2.8B
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B

LFWD vs GMED vs SYK vs MDT vs ISRG — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGSYK

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 4 of 6 comparable metrics.

MDT is the larger business by revenue, generating $35.5B annually — 1610.4x LFWD's $22M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to LFWD's -90.4%. On growth, GMED holds the edge at +27.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricLFWD logoLFWDLifeward Ltd.GMED logoGMEDGlobus Medical, I…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
RevenueTrailing 12 months$22M$3.1B$25.1B$35.5B$10.6B
EBITDAEarnings before interest/tax-$17M$745M$6.3B$9.4B$3.8B
Net IncomeAfter-tax profit-$20M$587M$3.2B$4.6B$3.0B
Free Cash FlowCash after capex-$17M$605M$4.3B$5.4B$2.8B
Gross MarginGross profit ÷ Revenue+38.3%+50.9%+63.5%+61.9%+66.3%
Operating MarginEBIT ÷ Revenue-76.7%+17.2%+22.4%+17.9%+30.5%
Net MarginNet income ÷ Revenue-90.4%+18.9%+12.9%+13.0%+28.2%
FCF MarginFCF ÷ Revenue-76.4%+19.5%+17.1%+15.2%+26.8%
Rev. Growth (YoY)Latest quarter vs prior year-32.7%+27.0%+11.4%+8.8%+23.0%
EPS Growth (YoY)Latest quarter vs prior year+82.7%+66.7%+56.0%-11.9%+18.8%
ISRG leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

MDT leads this category, winning 4 of 7 comparable metrics.

At 21.6x trailing earnings, MDT trades at a 63% valuation discount to ISRG's 57.6x P/E. Adjusting for growth (PEG ratio), GMED offers better value at 0.70x vs MDT's 35.17x — a lower PEG means you pay less per unit of expected earnings growth.

MetricLFWD logoLFWDLifeward Ltd.GMED logoGMEDGlobus Medical, I…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
Market CapShares × price$10M$11.5B$112.7B$99.9B$161.1B
Enterprise ValueMkt cap + debt − cash$10M$11.1B$123.5B$126.2B$158.0B
Trailing P/EPrice ÷ TTM EPS-0.39x21.70x35.03x21.60x57.62x
Forward P/EPrice ÷ next-FY EPS est.16.70x19.06x13.80x43.35x
PEG RatioP/E ÷ EPS growth rate0.70x2.36x35.17x2.65x
EV / EBITDAEnterprise value multiple18.51x20.31x14.32x43.62x
Price / SalesMarket cap ÷ Revenue0.47x3.92x4.49x2.98x16.00x
Price / BookPrice ÷ Book value/share9.33x2.55x5.02x2.08x9.17x
Price / FCFMarket cap ÷ FCF19.54x26.31x19.28x64.67x
MDT leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 5 of 9 comparable metrics.

ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-146 for LFWD. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to SYK's 0.66x. On the Piotroski fundamental quality scale (0–9), GMED scores 9/9 vs LFWD's 3/9, reflecting strong financial health.

MetricLFWD logoLFWDLifeward Ltd.GMED logoGMEDGlobus Medical, I…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
ROE (TTM)Return on equity-145.5%+13.0%+15.0%+9.4%+16.9%
ROA (TTM)Return on assets-78.4%+11.3%+6.9%+175.8%+14.8%
ROICReturn on invested capital-122.9%+8.9%+11.4%+6.0%+15.0%
ROCEReturn on capital employed-108.5%+10.4%+13.0%+7.5%+16.5%
Piotroski ScoreFundamental quality 0–939666
Debt / EquityFinancial leverage0.19x0.03x0.66x0.59x0.02x
Net DebtTotal debt minus cash-$585,000-$408M$10.8B$26.3B-$3.1B
Cash & Equiv.Liquid assets$2M$526M$4.0B$2.2B$3.4B
Total DebtShort + long-term debt$2M$119M$14.9B$28.5B$303M
Interest CoverageEBIT ÷ Interest expense-41.85x81.13x6.72x9.08x
ISRG leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

ISRG leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ISRG five years ago would be worth $15,873 today (with dividends reinvested), compared to $476 for LFWD. Over the past 12 months, GMED leads with a +19.0% total return vs LFWD's -58.3%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.4% vs LFWD's -49.3% — a key indicator of consistent wealth creation.

MetricLFWD logoLFWDLifeward Ltd.GMED logoGMEDGlobus Medical, I…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
YTD ReturnYear-to-date-9.6%-2.5%-15.2%-18.1%-19.3%
1-Year ReturnPast 12 months-58.3%+19.0%-22.5%-2.8%-15.4%
3-Year ReturnCumulative with dividends-87.0%+46.3%+5.5%-4.2%+49.6%
5-Year ReturnCumulative with dividends-95.2%+16.1%+21.5%-27.7%+58.7%
10-Year ReturnCumulative with dividends-100.0%+264.4%+187.1%+26.5%+554.2%
CAGR (3Y)Annualised 3-year return-49.3%+13.5%+1.8%-1.4%+14.4%
ISRG leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — GMED and MDT each lead in 1 of 2 comparable metrics.

MDT is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than GMED's 1.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GMED currently trades 83.9% from its 52-week high vs LFWD's 38.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricLFWD logoLFWDLifeward Ltd.GMED logoGMEDGlobus Medical, I…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
Beta (5Y)Sensitivity to S&P 5001.22x1.23x0.52x0.42x1.00x
52-Week HighHighest price in past year$17.76$101.40$404.87$106.33$603.88
52-Week LowLowest price in past year$0.67$51.79$289.91$77.16$427.84
% of 52W HighCurrent price vs 52-week peak+38.1%+83.9%+72.7%+73.3%+75.1%
RSI (14)Momentum oscillator 0–10049.845.024.327.342.4
Avg Volume (50D)Average daily shares traded11K998K2.1M7.8M1.8M
Evenly matched — GMED and MDT each lead in 1 of 2 comparable metrics.

Analyst Outlook

MDT leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: LFWD as "Buy", GMED as "Buy", SYK as "Buy", MDT as "Buy", ISRG as "Buy". Consensus price targets imply 59.0% upside for LFWD (target: $11) vs 29.6% for GMED (target: $110). For income investors, MDT offers the higher dividend yield at 3.57% vs SYK's 1.14%.

MetricLFWD logoLFWDLifeward Ltd.GMED logoGMEDGlobus Medical, I…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyBuy
Price TargetConsensus 12-month target$10.75$110.29$389.62$109.50$622.60
# AnalystsCovering analysts536504955
Dividend YieldAnnual dividend ÷ price+1.1%+3.6%
Dividend StreakConsecutive years of raises3436
Dividend / ShareAnnual DPS$3.36$2.78
Buyback YieldShare repurchases ÷ mkt cap0.0%+2.6%0.0%+3.2%+1.4%
MDT leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

ISRG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MDT leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 3 of 6 categories
Loading custom metrics...

LFWD vs GMED vs SYK vs MDT vs ISRG: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is LFWD or GMED or SYK or MDT or ISRG a better buy right now?

For growth investors, Intuitive Surgical, Inc.

(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus -14. 1% for Lifeward Ltd. (LFWD). Medtronic plc (MDT) offers the better valuation at 21. 6x trailing P/E (13. 8x forward), making it the more compelling value choice. Analysts rate Lifeward Ltd. (LFWD) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — LFWD or GMED or SYK or MDT or ISRG?

On trailing P/E, Medtronic plc (MDT) is the cheapest at 21.

6x versus Intuitive Surgical, Inc. at 57. 6x. On forward P/E, Medtronic plc is actually cheaper at 13. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Globus Medical, Inc. wins at 0. 54x versus Medtronic plc's 35. 17x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — LFWD or GMED or SYK or MDT or ISRG?

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +58. 7%, compared to -95. 2% for Lifeward Ltd. (LFWD). Over 10 years, the gap is even starker: ISRG returned +549. 2% versus LFWD's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — LFWD or GMED or SYK or MDT or ISRG?

By beta (market sensitivity over 5 years), Medtronic plc (MDT) is the lower-risk stock at 0.

42β versus Globus Medical, Inc. 's 1. 23β — meaning GMED is approximately 190% more volatile than MDT relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 66% for Stryker Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — LFWD or GMED or SYK or MDT or ISRG?

By revenue growth (latest reported year), Intuitive Surgical, Inc.

(ISRG) is pulling ahead at 20. 5% versus -14. 1% for Lifeward Ltd. (LFWD). On earnings-per-share growth, the picture is similar: Globus Medical, Inc. grew EPS 422. 7% year-over-year, compared to 8. 2% for Stryker Corporation. Over a 3-year CAGR, LFWD leads at 58. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — LFWD or GMED or SYK or MDT or ISRG?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -90. 4% for Lifeward Ltd. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -76. 7% for LFWD. At the gross margin level — before operating expenses — GMED leads at 67. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is LFWD or GMED or SYK or MDT or ISRG more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Globus Medical, Inc. (GMED) is the more undervalued stock at a PEG of 0. 54x versus Medtronic plc's 35. 17x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Medtronic plc (MDT) trades at 13. 8x forward P/E versus 43. 3x for Intuitive Surgical, Inc. — 29. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LFWD: 59. 0% to $10. 75.

08

Which pays a better dividend — LFWD or GMED or SYK or MDT or ISRG?

In this comparison, MDT (3.

6% yield), SYK (1. 1% yield) pay a dividend. LFWD, GMED, ISRG do not pay a meaningful dividend and should not be held primarily for income.

09

Is LFWD or GMED or SYK or MDT or ISRG better for a retirement portfolio?

For long-horizon retirement investors, Stryker Corporation (SYK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

52), 1. 1% yield, +179. 2% 10Y return). Both have compounded well over 10 years (SYK: +179. 2%, LFWD: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between LFWD and GMED and SYK and MDT and ISRG?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: LFWD is a small-cap quality compounder stock; GMED is a mid-cap high-growth stock; SYK is a mid-cap quality compounder stock; MDT is a mid-cap income-oriented stock; ISRG is a mid-cap high-growth stock. SYK, MDT pay a dividend while LFWD, GMED, ISRG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

LFWD

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 22%
Run This Screen
Stocks Like

GMED

High-Growth Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 13%
  • Net Margin > 11%
Run This Screen
Stocks Like

SYK

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Stocks Like

MDT

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform LFWD and GMED and SYK and MDT and ISRG on the metrics below

Revenue Growth>
%
(LFWD: -32.7% · GMED: 27.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.